Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
  1. Home
  2. Publications
  3. Supplementary Figure S4 from A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Supplementary Figure S4 from A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Authors:
  • PRPaul B. Romesser
    Paul B. Romesser
  • JCJaume Capdevila
    Jaume Capdevila
  • RGRocio Garcia-Carbonero
    Rocio Garcia-Carbonero
  • TPTony Philip
    Tony Philip
  • CMCarlos Fernandez Martos
    Carlos Fernandez Martos
  • RTRichard Tuli
    Richard Tuli
  • ARAlmudena Rodriguez-Gutierrez
    Almudena Rodriguez-Gutierrez
  • MKMirjam Kuipers
    Mirjam Kuipers
  • ABAndreas Becker
    Andreas Becker
  • ACAnna Coenen-Stass
    Anna Coenen-Stass
  • BSBarbara Sarholz
    Barbara Sarholz
  • XYXiaoli You
    Xiaoli You

Open Access
Publisher website
Google Scholar
  • 16 February 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.25232425
Abstract
. pDNA-PK/tDNA-PK ratios in PBMCs stimulated with bleomycin, pre- and post-dosing with peposertib.
Keywords
  • CHEMOTHERAPY
  • CLINICAL TRIAL RESULTS
  • CLINICAL-STAGE RESEARCH
  • DNA DAMAGE AND REPAIR
  • GASTROINTESTINAL CANCERS
  • RADIATION ONCOLOGY
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.